These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 15147594)

  • 21. Impaired neuronal plasticity in transgenic mice expressing human apolipoprotein E4 compared to E3 in a model of entorhinal cortex lesion.
    White F; Nicoll JA; Roses AD; Horsburgh K
    Neurobiol Dis; 2001 Aug; 8(4):611-25. PubMed ID: 11493026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
    Martins CA; Oulhaj A; de Jager CA; Williams JH
    Neurology; 2005 Dec; 65(12):1888-93. PubMed ID: 16380608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
    Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
    Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
    Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
    Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Apolipoprotein E polymorphism and Alzheimer disease].
    van der Weide J; Steijns LS; Teepen JL; Noback WJ; Klaverwijden G
    Tijdschr Gerontol Geriatr; 1996 Apr; 27(2):73-7. PubMed ID: 8669075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new promoter polymorphism in the alpha-1-antichymotrypsin gene is a disease modifier of Alzheimer's disease.
    Licastro F; Chiappelli M; Grimaldi LM; Morgan K; Kalsheker N; Calabrese E; Ritchie A; Porcellini E; Salani G; Franceschi M; Canal N
    Neurobiol Aging; 2005 Apr; 26(4):449-53. PubMed ID: 15653173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preclinical memory profile in Alzheimer patients with and without allele APOE-epsilon4.
    Estévez-González A; García-Sánchez C; Boltes A; Otermín P; Baiget M; Escartín A; del Rio E; Gironell A; Kulisevsky J
    Eur Neurol; 2004; 51(4):199-205. PubMed ID: 15159600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain-derived neurotrophic factor, apolipoprotein E genetic variants and cognitive performance in Alzheimer's disease.
    Nacmias B; Piccini C; Bagnoli S; Tedde A; Cellini E; Bracco L; Sorbi S
    Neurosci Lett; 2004 Sep; 367(3):379-83. PubMed ID: 15337270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective memory and apolipoprotein E in healthy aging and early stage Alzheimer's disease.
    Duchek JM; Balota DA; Cortese M
    Neuropsychology; 2006 Nov; 20(6):633-44. PubMed ID: 17100508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein E genotype and age-related myelin breakdown in healthy individuals: implications for cognitive decline and dementia.
    Bartzokis G; Lu PH; Geschwind DH; Edwards N; Mintz J; Cummings JL
    Arch Gen Psychiatry; 2006 Jan; 63(1):63-72. PubMed ID: 16389198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein E and prospective memory in normally aging adults.
    Driscoll I; McDaniel MA; Guynn MJ
    Neuropsychology; 2005 Jan; 19(1):28-34. PubMed ID: 15656760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Scaling of visuospatial attention undergoes differential longitudinal change as a function of APOE genotype prior to old age: results from the NIMH BIOCARD study.
    Greenwood PM; Sunderland T; Putnam K; Levy J; Parasuraman R
    Neuropsychology; 2005 Nov; 19(6):830-40. PubMed ID: 16351359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Object naming and semantic fluency among individuals with genetic risk for Alzheimer's disease.
    Miller KJ; Rogers SA; Siddarth P; Small GW
    Int J Geriatr Psychiatry; 2005 Feb; 20(2):128-36. PubMed ID: 15660408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropsychological measures in normal individuals that predict subsequent cognitive decline.
    Blacker D; Lee H; Muzikansky A; Martin EC; Tanzi R; McArdle JJ; Moss M; Albert M
    Arch Neurol; 2007 Jun; 64(6):862-71. PubMed ID: 17562935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The apolipoprotein E gene and Alzheimer disease phenotype].
    Kurz A; Egensperger R; Lautenschlager N; Haupt M; Altland K; Graeber MB; Müller U
    Z Gerontol Geriatr; 1995; 28(3):195-9. PubMed ID: 7664194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive impairment in Alzheimer's disease is modified by APOE genotype.
    van der Vlies AE; Pijnenburg YA; Koene T; Klein M; Kok A; Scheltens P; van der Flier WM
    Dement Geriatr Cogn Disord; 2007; 24(2):98-103. PubMed ID: 17596691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].
    Rosich-Estragó M; Figuera-Terré L; Mulet-Pérez B; Arrufat-Cardús MT; Pascual San Emeterio A; Arbeola-Rigau I; Labad-Alquézar A; Vilella-Cuadrada E
    Rev Neurol; 2004 May 1-15; 38(9):801-7. PubMed ID: 15152345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. APOE genotype influences functional status among elderly without dementia.
    Albert SM; Gurland B; Maestre G; Jacobs DM; Stern Y; Mayeux R
    Am J Med Genet; 1995 Dec; 60(6):583-7. PubMed ID: 8825902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allele epsilon 4 of APOE is a stronger predictor of Alzheimer risk in Sicily than in continental South Italy.
    Bosco P; Guéant-Rodríguez RM; Anello G; Spada RS; Romano A; Caraci F; Ferri R; Guéant JL
    Neurosci Lett; 2005 Nov; 388(3):168-72. PubMed ID: 16040191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.